Clinical Trials Sponsored by New York Glaucoma Research Institute

Total 1422 results

New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Nalrexone Facilitated Discontinuation of Buprenorphine

Stable Opioid Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa

Anorexia Nervosa | Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Depression | Suicidal Ideation

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression

Depression | Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder

Suicide | Borderline Personality Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use Disorders (CTN-0044)

Substance Abuse

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Pergolide Treatment for Substance Abusers - 4

Substance-Related Disorders | Cocaine-Related Disorders

United States
New York State Psychiatric Institute

Completed

Women's Treatment for Trauma and Substance Use Disorders - 1

Substance-Related Disorders

United States
New York State Psychiatric Institute

Completed

HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1

Behavior Therapy

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.

Schizophrenia

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS

HIV Infections | Fatigue

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Enhancing the Outcome of Skills Training for People With Schizophrenia

Schizophrenia

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Improving Retention of Hispanics Receiving Antidepressant Therapy

Depressive Disorder | Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Withdrawn

Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse

Marijuana Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa

Anorexia Nervosa | Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site

Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness

Psychotic Disorders

United States
Craig L Slingluff, Jr
Cancer Research Institute, New York City; Ludwig Institute for Cancer Research

Terminated

Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma (Mel63; CHAMP)

Melanoma

United States
Ludwig Institute for Cancer Research
Cancer Research Institute, New York City; MedImmune LLC; Cure Brain Cancer Foundation...

Completed

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Glioblastoma

United States, Australia
Andrew Talal
Patient-Centered Outcomes Research Institute

Active, not recruiting

Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals

Hepatitis C

United States
New York State Psychiatric Institute
University of Pennsylvania; Columbia University

Recruiting

Training Providers to Conduct PRIDES-sSA (PRIDE-sSA)

Common Mental Disorders | Severe Mental Disorder

Mozambique
New York State Psychiatric Institute
Callen-Lorde Community Health Center

Completed

Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS

HIV Infection | Fatigue

United States
New York Head & Neck Institute
Ohio State University; Biolase Inc

Completed

Laser Tongue Debridement for Oral Malodor

Halitosis

United States
Hospital for Special Surgery, New York
Orthopedic Research and Education Foundation

Active, not recruiting

Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears

Rotator Cuff Tear | Muscle Atrophy | Tendon Tear

United States
Cardiovascular Research Foundation, New York
Boston Scientific Corporation; The Medicines Company

Completed

Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction

Myocardial Infarction

United States
State University of New York - Downstate Medical...
National Institute of Nursing Research (NINR)

Completed

Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy

HIV/AIDS

United States
Pulmatrix Inc.
The VA Western New York Healthcare System; Buffalo Institute For Medical Research

Completed

Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) Sputum

Chronic Obstructive Pulmonary Disease

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); Nathan Kline Institute for Psychiatric...

Suspended

D-serine AudRem: R33 Phase

Schizophrenia | Schizo Affective Disorder

United States
Rutgers, The State University of New Jersey
New York State Institute for Basic Research; New Jersey Governor's Council...

Active, not recruiting

Propranolol for Challenging Behaviors in Autism

Aggression | Self-Injurious Behavior | Autism Spectrum Disorder | Developmental Disability | Challenging Behavior

United States
Columbia University
National Institute of Nursing Research (NINR); Visiting Nurse Service of New...

Completed

Improving Patient Prioritization During Hospital-homecare Transition (PREVENT)

Diabetes Mellitus, Type 2 | Renal Failure | Congestive Heart Failure | Dyspnea | Obstructive Pulmonary Disease

United States
Cancer Insight, LLC
Bristol-Myers Squibb; Cancer Research Institute, New York City; Akamis Bio

Active, not recruiting

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)

Metastatic Pancreatic Adenocarcinoma

United States
New York State Psychiatric Institute
USWM, LLC (dba US WorldMeds)

Completed

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Opioid-use Disorder

United States
New York State Psychiatric Institute
United States Department of Defense

Completed

Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil

Mild Cognitive Impairment

United States
New York State Psychiatric Institute
American Foundation for Suicide Prevention

Completed

Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior

Suicidal and Self-injurious Behaviour | Monopolar Depression, Single Episode or Unspecified

United States
New York State Psychiatric Institute
University of Pennsylvania; Columbia University

Recruiting

Community I-STAR Mozambique: Community Implementation of SBIRT Using Technology for Alcohol Use Reduction in Mozambique

mSBIRT - Mobile Screening, Brief Intervention, Referral to Treatment | SBIRT-CTS - Screening, Brief Intervention, Referral to Treatment Conventional Training and Supervision Strategy

Mozambique
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb; Cancer Research Institute, New York City; Apexigen, Inc.

Completed

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

United States
New York State Psychiatric Institute
Merck Sharp & Dohme LLC; Stanley Medical Research Institute; Sheba Medical Center

Terminated

Add-on Simvastatin in Schizophrenia Trial (ASSIST)

Schizophrenia

Israel
SoundBite Medical Solutions, Inc.
ethica Clinical Research Inc.; Cardiovascular Research Foundation, New York

Terminated

Safety and Efficacy Study of the SoundBite™ Crossing System With ACTIVE Wire in Coronary CTOs. (ACTIVE)

Chronic Total Occlusion of Coronary Artery

United States, Canada
New York State Psychiatric Institute
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

Alzheimer Disease | Mild Cognitive Impairment | Delirium, Dementia, Amnestic, Cognitive Disorders

United States
City University of New York
National Institute of Mental Health (NIMH); New York City Department of Health...

Active, not recruiting

Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program (D2S)

Hiv

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); MediciNova

Completed

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

Opioid Dependence | Opioid Abuse

United States

Clinical Trials Sponsored by New York Glaucoma Research Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations